Hello, everyone, and how are you today? We are doing just fine, thank you, since the middle of the week is already here, which means there is much to do. No doubt, you can relate on some level. Of course, this also means that we are edging closer to another weekend. So please join us as we grab a cup of stimulation – our choice today is glazed doughnut – and tackle the online calls and deadlines that are piling up. Meanwhile, here is the latest grab of items of interest to help you along. Hope you conquer the world today and do stay in touch…
Robert Califf escaped largely unscathed from a two-hour hearing vetting him to be U.S. Food and Drug Administration commissioner, STAT tells us. He gushed about his love of high-quality data, skillfully navigated questions on hot-button topics like abortion and drug pricing, and even had personal anecdotes about Covid-19 testing and opioid prescribing at the ready. His only stumble came when he clearly frustrated lawmakers with his responses to pointed questions about the FDA’s approach toward approving opioid drugs, including its general reluctance to crack down on long-term prescribing of opioids and its recent decisions to approve new high-dose opioids. Unlock this article by subscribing to STAT+ and enjoy your first 30 days free! GET STARTED STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What’s included? Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. This name will appear with your comment
https://www.statnews.com/pharmalot/2021/12/15/fda-califf-covid19-vaccine-omicron-pfizer-jnj/
